Free Trial
NASDAQ:FTXH

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News

$27.47 -0.29 (-1.04%)
As of 02:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

Key Stats

Today's Range
$27.48
$27.56
50-Day Range
$25.44
$28.02
52-Week Range
$23.28
$29.72
Volume
580 shs
Average Volume
7,250 shs
Market Capitalization
$15.11 million
Assets Under Management
$15.27 million
Dividend Yield
1.60%
Net Expense Ratio
0.60%
Aggregate Rating
Moderate Buy

ETF Overview

First Trust Nasdaq Pharmaceuticals ETF Expenses

TypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.60%0.56%0.56%0.54%0.53%
Other Expenses0.00%0.47%0.56%0.52%0.56%
Total Expense0.60%0.75%0.76%0.73%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%
Net Expense0.60%0.60%0.63%0.63%0.60%
Receive FTXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FTXH ETF News Headlines

Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
Surprising Analyst 12-Month Target For FTXH
Solid Q4 Earnings Fail to Impress Pharma ETFs
See More Headlines

FTXH ETF - Frequently Asked Questions

First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.97 at the beginning of 2025. Since then, FTXH shares have increased by 1.9% and is now trading at $27.4710.

First Trust Nasdaq Pharmaceuticals ETF's top institutional investors include Envestnet Asset Management Inc. (3.23%), Ameritas Investment Partners Inc. (2.86%), WMG Financial Advisors LLC (1.97%) and Vivaldi Capital Management LP (1.71%).

Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Cannabis Wheaton Income (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC) and Biocorrx (BICX).

Fund Details

Issuer
First Trust
Fund Name
First Trust Nasdaq Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:FTXH
Inception Date
9/20/2016
Fund Manager
Daniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq US Smart Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
49

Fund Statistics

Assets Under Management
$15.27 million
Average Daily Volume
$1.47 thousand
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Old Mission

Options

Optionable
N/A
Short Interest
700 shs

Miscellaneous

Beta
0.70
Creation Unit
50,000
Creation Fee
$500.00
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Top 10 FTXH Holdings

FTXH Sector Exposure

FTXH Industry Exposure


This page (NASDAQ:FTXH) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners